Published in Proteomics on April 01, 2012
LOXL4 is induced by transforming growth factor β1 through Smad and JunB/Fra2 and contributes to vascular matrix remodeling. Mol Cell Biol (2013) 0.91
Phosphorylation Regulates Id2 Degradation and Mediates the Proliferation of Neural Precursor Cells. Stem Cells (2016) 0.77
Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. Circulation (2016) 0.76
Two dimensional gel phosphoproteome of peripheral blood mononuclear cells: comparison between two enrichment methods. Proteome Sci (2014) 0.75
MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy. PLoS One (2017) 0.75
Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem (1996) 45.70
Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal (2010) 8.61
From promiscuity to precision: protein phosphatases get a makeover. Mol Cell (2009) 4.17
Separation and detection of large phosphoproteins using Phos-tag SDS-PAGE. Nat Protoc (2009) 1.97
Alkaline phosphatase activity and pH optima. J Biol Chem (1951) 1.82
Improved Phos-tag SDS-PAGE under neutral pH conditions for advanced protein phosphorylation profiling. Proteomics (2010) 1.70
Expanding the subproteome of the inner mitochondria using protein separation technologies: one- and two-dimensional liquid chromatography and two-dimensional gel electrophoresis. Mol Cell Proteomics (2006) 1.48
Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria. Mol Cell Proteomics (2010) 1.41
Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circ Cardiovasc Genet (2009) 1.32
Analysis of steady-state protein phosphorylation in mitochondria using a novel fluorescent phosphosensor dye. J Biol Chem (2003) 1.32
Why does troponin I have so many phosphorylation sites? Fact and fancy. J Mol Cell Cardiol (2010) 1.25
Isolation of the protein backbone of an arabinogalactan-protein from the styles of Nicotiana alata and characterization of a corresponding cDNA. Plant Cell (1994) 1.19
Membrane protein phosphotyrosine phosphatase in rabbit kidney. Proteolysis activates the enzyme and generates soluble catalytic fragments. Biochem J (1987) 1.10
Intact protein separation by chromatographic and/or electrophoretic techniques for top-down proteomics. J Chromatogr A (2011) 1.04
Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure. J Mol Cell Cardiol (2008) 1.02
Optimization of paper bridge loading for 2-DE analysis in the basic pH region: application to the mitochondrial subproteome. Proteomics (2006) 0.98
Phosphorylation of the F(1)F(o) ATP synthase beta subunit: functional and structural consequences assessed in a model system. Circ Res (2009) 0.97
Flicking the switches: phosphorylation of serine/threonine protein phosphatases. Semin Cancer Biol (1995) 0.96
Phosphoproteome analysis. Biosci Rep (2005) 0.95
Subfractionation of heart tissue: the "in sequence" myofilament protein extraction of myocardial tissue. Methods Mol Biol (2007) 0.94
Divide and conquer: the application of organelle proteomics to heart failure. Circ Res (2011) 0.94
Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC. Proteomics (2005) 0.93
Detection of phosphorylation patterns in rat cortical neurons by combining phosphatase treatment and DIGE technology. Proteomics (2006) 0.92
Efficient identification of phosphorylation by mass spectrometric phosphopeptide fingerprinting. Anal Chem (2008) 0.83
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature (2009) 13.28
The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res (2013) 3.92
Guidelines for the next 10 years of proteomics. Proteomics (2006) 3.61
Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clin Appl (2007) 2.84
Circulating transforming growth factor-beta in Marfan syndrome. Circulation (2009) 2.69
Cytoprotective role of Ca2+- activated K+ channels in the cardiac inner mitochondrial membrane. Science (2002) 2.23
Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ Res (2006) 2.20
Uromodulin levels associate with a common UMOD variant and risk for incident CKD. J Am Soc Nephrol (2009) 2.10
Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart. Circulation (2012) 2.05
Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One (2011) 1.79
Characterization of the cardiac myosin binding protein-C phosphoproteome in healthy and failing human hearts. J Mol Cell Cardiol (2013) 1.75
Moderate heart dysfunction in mice with inducible cardiomyocyte-specific excision of the Serca2 gene. J Mol Cell Cardiol (2009) 1.72
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J (2009) 1.71
Investigation of an albumin-enriched fraction of human serum and its albuminome. Proteomics Clin Appl (2007) 1.68
Stunned peri-infarct canine myocardium is characterized by degradation of troponin T, not troponin I. Cardiovasc Res (2004) 1.65
Comparison of multiplex immunoassay platforms. Clin Chem (2009) 1.61
Effects of congestive heart failure on Ca2+ handling in skeletal muscle during fatigue. Circ Res (2006) 1.57
Diastolic dysfunction in alveolar hypoxia: a role for interleukin-18-mediated increase in protein phosphatase 2A. Cardiovasc Res (2008) 1.49
Expanding the subproteome of the inner mitochondria using protein separation technologies: one- and two-dimensional liquid chromatography and two-dimensional gel electrophoresis. Mol Cell Proteomics (2006) 1.48
Identification and quantification of S-nitrosylation by cysteine reactive tandem mass tag switch assay. Mol Cell Proteomics (2011) 1.40
Ultrastructure and regulation of lateralized connexin43 in the failing heart. Circ Res (2010) 1.40
Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure. Circulation (2005) 1.38
Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes. Proteomics (2010) 1.38
p21-activated kinase increases the calcium sensitivity of rat triton-skinned cardiac muscle fiber bundles via a mechanism potentially involving novel phosphorylation of troponin I. Circ Res (2002) 1.37
Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J Thorac Cardiovasc Surg (2008) 1.35
Multiplex assays for biomarker research and clinical application: translational science coming of age. Proteomics Clin Appl (2010) 1.35
Sodium accumulation promotes diastolic dysfunction in end-stage heart failure following Serca2 knockout. J Physiol (2009) 1.34
Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circ Cardiovasc Genet (2009) 1.32
Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy. Circ Res (2011) 1.32
B-MYB is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells. PLoS One (2008) 1.32
Echocardiographic parameters discriminating myocardial infarction with pulmonary congestion from myocardial infarction without congestion in the mouse. J Appl Physiol (1985) (2004) 1.27
The Human Eye Proteome Project: perspectives on an emerging proteome. Proteomics (2013) 1.23
Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure. Physiol Genomics (2011) 1.23
Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function. Mol Biol Cell (2010) 1.23
Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database. Mol Cell Proteomics (2005) 1.23
Strategy for analysis of cardiac troponins in biological samples with a combination of affinity chromatography and mass spectrometry. Clin Chem (2003) 1.22
Site-mapping of in vitro S-nitrosation in cardiac mitochondria: implications for cardioprotection. Mol Cell Proteomics (2010) 1.21
Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice. Am J Physiol Heart Circ Physiol (2005) 1.20
Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system. Circ Res (2013) 1.19
Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: report from a National Heart, Lung, and Blood Institute workshop. Circulation (2013) 1.18
A robust, streamlined, and reproducible method for proteomic analysis of serum by delipidation, albumin and IgG depletion, and two-dimensional gel electrophoresis. Proteomics (2005) 1.18
Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress. J Mol Cell Cardiol (2012) 1.18
Reduced SERCA2 abundance decreases the propensity for Ca2+ wave development in ventricular myocytes. Cardiovasc Res (2009) 1.17
The mouse C2C12 myoblast cell surface N-linked glycoproteome: identification, glycosite occupancy, and membrane orientation. Mol Cell Proteomics (2009) 1.16
Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity. Cardiovasc Res (2002) 1.15
A mighty small heart: the cardiac proteome of adult Drosophila melanogaster. PLoS One (2011) 1.13
C-terminal truncation of cardiac troponin I causes divergent effects on ATPase and force: implications for the pathophysiology of myocardial stunning. Circ Res (2003) 1.13
Quantitative proteomics analysis of human endothelial cell membrane rafts: evidence of MARCKS and MRP regulation in the sphingosine 1-phosphate-induced barrier enhancement. Mol Cell Proteomics (2007) 1.13
The C terminus of cardiac troponin I stabilizes the Ca2+-activated state of tropomyosin on actin filaments. Circ Res (2009) 1.11
Effective removal of albumin from serum. Proteomics (2005) 1.11
Extreme sarcoplasmic reticulum volume loss and compensatory T-tubule remodeling after Serca2 knockout. Proc Natl Acad Sci U S A (2012) 1.09
Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes. Mol Biotechnol (2004) 1.08
Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group. Circulation (2010) 1.07
National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report. Circulation (2004) 1.07
Elevated levels of activin A in heart failure: potential role in myocardial remodeling. Circulation (2004) 1.07
Proteomics and heart disease: identifying biomarkers of clinical utility. Expert Rev Proteomics (2006) 1.06
Assessment of albumin removal from an immunoaffinity spin column: critical implications for proteomic examination of the albuminome and albumin-depleted samples. Proteomics (2009) 1.05
Plasma glial fibrillary acidic protein levels in children with sickle cell disease. Am J Hematol (2011) 1.03
Biomarker discovery: proteome fractionation and separation in biological samples. Physiol Genomics (2007) 1.03
Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure. J Mol Cell Cardiol (2008) 1.02
Application of reversed phase high performance liquid chromatography for subproteomic analysis of cardiac muscle. Proteomics (2002) 1.02
Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function. Circ Res (2012) 1.02
Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflow. Curr Protoc Mol Biol (2009) 1.02
Mitochondrial proteomics. Undercover in the lipid bilayer. Basic Res Cardiol (2003) 1.00
Mechanisms of gap junction traffic in health and disease. J Cardiovasc Pharmacol (2009) 1.00
Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in Tg(alphaMHC-MerCreMer) mice. Am J Physiol Heart Circ Physiol (2010) 1.00
Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway. PLoS One (2011) 0.99
Secreted proteins as a fundamental source for biomarker discovery. Proteomics (2012) 0.98
Optimization of paper bridge loading for 2-DE analysis in the basic pH region: application to the mitochondrial subproteome. Proteomics (2006) 0.98
Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am J Physiol Regul Integr Comp Physiol (2002) 0.98
Nitration of tyrosine 92 mediates the activation of rat microsomal glutathione s-transferase by peroxynitrite. J Biol Chem (2005) 0.97
Phosphorylation of the F(1)F(o) ATP synthase beta subunit: functional and structural consequences assessed in a model system. Circ Res (2009) 0.97
Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3β. J Clin Invest (2014) 0.97
Improvements in two-dimensional gel electrophoresis by utilizing a low cost "in-house" neutral pH sodium dodecyl sulfate-polyacrylamide gel electrophoresis system. Proteomics (2005) 0.96
Developing the next generation of cardiac markers: disease-induced modifications of troponin I. Prog Cardiovasc Dis (2005) 0.95
Subfractionation of heart tissue: the "in sequence" myofilament protein extraction of myocardial tissue. Methods Mol Biol (2007) 0.94
Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction. Cardiovasc Res (2003) 0.94
Divide and conquer: the application of organelle proteomics to heart failure. Circ Res (2011) 0.94
A cell surfaceome map for immunophenotyping and sorting pluripotent stem cells. Mol Cell Proteomics (2012) 0.94
Redox signaling and protein phosphorylation in mitochondria: progress and prospects. J Bioenerg Biomembr (2009) 0.93
Cardiac stem/progenitor cells, secreted proteins, and proteomics. FEBS Lett (2009) 0.93
Ca(2+) wave probability is determined by the balance between SERCA2-dependent Ca(2+) reuptake and threshold SR Ca(2+) content. Cardiovasc Res (2011) 0.92
Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli. FEBS J (2013) 0.92
Heart disease, clinical proteomics and mass spectrometry. Dis Markers (2004) 0.92
Post-translational modifications of ATP synthase in the heart: biology and function. J Bioenerg Biomembr (2009) 0.92
A rapid, economical, and reproducible method for human serum delipidation and albumin and IgG removal for proteomic analysis. Methods Mol Biol (2007) 0.91
Transforming growth factor-β and inflammation in vascular (type IV) Ehlers-Danlos syndrome. Circ Cardiovasc Genet (2014) 0.91
Mice carrying a conditional Serca2(flox) allele for the generation of Ca(2+) handling-deficient mouse models. Cell Calcium (2009) 0.91
Desmin modifications associate with amyloid-like oligomers deposition in heart failure. Cardiovasc Res (2014) 0.90
A dominant STIM1 mutation causes Stormorken syndrome. Hum Mutat (2014) 0.90
Redox regulation of mitochondrial ATP synthase. Trends Cardiovasc Med (2013) 0.90
Proteomic alterations in heat shock protein 27 and identification of phosphoproteins in ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve. J Mol Cell Cardiol (2007) 0.90
Two-dimensional gel electrophoresis database of murine R1 embryonic stem cells. Proteomics (2004) 0.89
Proteomic evaluation reveals that olfactory ensheathing cells but not Schwann cells express calponin. Glia (2006) 0.89
Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C. Biochemistry (2003) 0.89